Evidence map›Paper›PMID 41128984›Full record

ArticleDiscover oncology2025

Correction: Oncogenic EME1 promotes tumor progression and immune modulation in human cancers with therapeutic targeting potential.

Muhammad Alaa Eldeen, Abdelrahman Mostafa, Farag Mamdouh, Waleed K Abdulsahib, Dalal Sulaiman Alshaya, Eman Fayad, Hassan M Otifi, Hesham M Hassan, Mohammed Alshehri, Aiysha Althobaiti and 2 more

Abstract readPublished Erratum
PubMed Full text at PMC Publisher
In one paragraph

Article in Discover oncology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

12 authors.

Muhammad Alaa EldeenCell Biology, Histology and Genetics Division, Zoology Department, Faculty of Science, Zagazig University, Zagazig, Egypt. dr.muhammadalaa@gmail.com.
Abdelrahman MostafaBiotechnology Division, Zoology Department, Faculty of Science, Benha University, Banha, Al Qalyubia Governorate, Egypt.
Farag MamdouhBiotechnology Division, Zoology Department, Faculty of Science, Benha University, Banha, Al Qalyubia Governorate, Egypt.
Waleed K AbdulsahibPharmacology and Toxicology Department, College of Pharmacy, Al Farahidi University, Baghdad, 00965, Iraq.
Dalal Sulaiman AlshayaDepartment of Biology, College of Science, Princess Nourah Bint Abdulrahman University, P.O. Box 84428, 11671, Riyadh, Saudi Arabia.
Eman FayadDepartment of Biotechnology, College of Sciences, Taif University, P.O. Box 11099, 21944, Taif, Saudi Arabia.
Hassan M OtifiPathology Department, College of Medicine, King Khalid University, P.O. Box 62529, Abha, Saudi Arabia.
Hesham M HassanPathology Department, College of Medicine, King Khalid University, P.O. Box 62529, Abha, Saudi Arabia.
Mohammed AlshehriDepartment of Child Health, College of Medicine, King Khalid University, P.O. Box 62529, Abha, Saudi Arabia.
Aiysha AlthobaitiDepartment of Community Health Sciences, College of Applied Medical Sciences, King Saud University, P.O.Box 10219, 11433, Riyadh, Saudi Arabia.
Ghadi AlsharifDepartment of Clinical Laboratory Sciences, College of Applied Medical Sciences, King Saud Bin Abdulaziz University for Health Sciences, P.O. Box 9515, 21423, Jeddah, Saudi Arabia.
Mohamed A SoltanDepartment of Microbiology and Immunology, Faculty of Pharmacy, Sinai University, Ismailia, 41611, Egypt.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Identifiers

PMID41128984
PMCPMC12549458

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.